Navidea Biopharmaceuticals (NAVB) To Announce Fourth Quarter And Full-Year 2013 Financial Results On Thursday, March 6, 2014
3/4/2014 6:59:49 AM
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the fourth quarter and full-year 2013, on Thursday, March 6, 2014 before the market opens. Company management will host a conference call and slide presentation via webcast, also on March 6, 2014, at 8:30 a.m. ET to discuss results and corporate developments.
Help employers find you! Check out all the jobs and post your resume.
comments powered by